Suppr超能文献

商业和公共支付方阿片类镇痛药处方政策:案例研究。

Commercial and public payer opioid analgesic prescribing policies: a case study.

机构信息

Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Drive, Suite 1B, Detroit, MI, 48201, USA.

Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Room 4144, Detroit, MI, 48201, USA.

出版信息

Subst Abuse Treat Prev Policy. 2021 Jan 6;16(1):4. doi: 10.1186/s13011-020-00340-z.

Abstract

BACKGROUND

One strategy to address the high number of U.S. opioid-related deaths is to restrict high-risk or inappropriate opioid analgesic prescribing and dispensing. Federal and state laws and regulations have implemented restrictions but less is known about commercial and public payers' policies aside from clinician anecdotal reports that these policies are increasing. To assess the number and types of policies with temporal trends, we examined commercial and public (Medicaid) payer policies in one state, Michigan, that has high opioid-related deaths and implemented opioid analgesic prescribing laws.

METHODS

Policies for seven large commercial payers and the public payer for 2012-2018 were reviewed and categorized by actions. Joinpoint regression was used to summarize temporal trends on number of policies for all payers and subgroups.

RESULTS

Across the 7 years, there were 529 action policies (75.57 (95% confidence intervals (CI) 35.93, 115.22) actions per year) with a range of 36 to 103 actions by payer. Limitations on number of days for initial prescriptions and prior authorizations were the most frequently implemented policy. The temporal trend showed a decline in new policies from 2012 to 2013 but a steady increase from 2014 to 2018 (average annual percent change or AAPC=29.6% (95% confidence intervals 13.2, 48.5%)). The public payer (n=47 policies) showed no increase in number of policies over time (AAPC=2.9% (95% CI -41.6, 61.6%).

CONCLUSIONS

The eight commercial and public payers implemented many new policies to restrict opioid analgesic prescribing with a steady increase in the number of such policies implemented from 2014 to 2018. This case study documented that at least in one state with high opioid-related deaths and multiple commercial payers, new and different policies were increasingly implemented creating barriers to patient care. The impact of these policies is understudied, complicating recommendation of best practices.

摘要

背景

解决美国大量阿片类药物相关死亡的策略之一是限制高危或不适当的阿片类镇痛药处方和配药。联邦和州法律和法规已经实施了限制,但除了临床医生的传闻报告表明这些政策正在增加之外,对于商业和公共支付者的政策知之甚少。为了评估具有时间趋势的政策数量和类型,我们检查了一个州(密歇根州)的商业和公共(医疗补助)支付者政策,该州阿片类药物相关死亡人数较高,并实施了阿片类镇痛药处方法律。

方法

审查了 2012-2018 年期间七个大型商业支付者和公共支付者的政策,并按行动进行了分类。使用 Joinpoint 回归总结了所有支付者和子组的政策数量的时间趋势。

结果

在 7 年期间,有 529 项行动政策(每年 75.57(95%置信区间(CI)35.93,115.22)项行动),每个支付者的政策范围为 36 至 103 项。限制初始处方和预先授权的天数是实施最多的政策。时间趋势显示,新政策从 2012 年到 2013 年呈下降趋势,但从 2014 年到 2018 年呈稳步上升趋势(平均年百分比变化或 AAPC=29.6%(95%置信区间 13.2, 48.5%))。公共支付者(n=47 项政策)在过去的时间内没有增加政策数量(AAPC=2.9%(95% CI -41.6, 61.6%))。

结论

八家商业和公共支付者实施了许多新政策来限制阿片类镇痛药的处方,从 2014 年到 2018 年,实施此类政策的数量稳步增加。这项案例研究记录了在一个阿片类药物相关死亡人数较高且有多个商业支付者的州,至少有新的和不同的政策正在不断实施,为患者护理制造障碍。这些政策的影响研究不足,使得最佳实践的建议变得复杂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b38/7789815/9f098408b603/13011_2020_340_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验